Answering the Big Clinical Questions in Brain Metastasis Management
Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors f...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.834122/full |
_version_ | 1819282340884512768 |
---|---|
author | John P. Kirkpatrick John P. Kirkpatrick |
author_facet | John P. Kirkpatrick John P. Kirkpatrick |
author_sort | John P. Kirkpatrick |
collection | DOAJ |
description | Management of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors face in the clinic. Successfully answering these questions requires knowledge of the clinical evidence, thoughtful discussion of the patient’s goals of care and collaboration in a multi-disciplinary setting. |
first_indexed | 2024-12-24T01:14:02Z |
format | Article |
id | doaj.art-a515a54ff5f246688204307902daacb9 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-12-24T01:14:02Z |
publishDate | 2022-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-a515a54ff5f246688204307902daacb92022-12-21T17:22:48ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-01-011110.3389/fonc.2021.834122834122Answering the Big Clinical Questions in Brain Metastasis ManagementJohn P. Kirkpatrick0John P. Kirkpatrick1Department of Radiation Oncology, Duke Cancer Institute, Durham, NC, United StatesDepartment of Neurosurgery, Duke Cancer Institute, Durham, NC, United StatesManagement of brain metastases is challenging, both because of the historically guarded prognosis and evolving, more efficacious treatment paradigms for metastatic cancer. This perspective addresses several of the important difficult questions that practitioners treating patients with brain tumors face in the clinic. Successfully answering these questions requires knowledge of the clinical evidence, thoughtful discussion of the patient’s goals of care and collaboration in a multi-disciplinary setting.https://www.frontiersin.org/articles/10.3389/fonc.2021.834122/fullbrain metastasesstereotactic radiosurgerywhole-brain radiotherapyhippocampal avoidancepalliative careleptomeningeal disease |
spellingShingle | John P. Kirkpatrick John P. Kirkpatrick Answering the Big Clinical Questions in Brain Metastasis Management Frontiers in Oncology brain metastases stereotactic radiosurgery whole-brain radiotherapy hippocampal avoidance palliative care leptomeningeal disease |
title | Answering the Big Clinical Questions in Brain Metastasis Management |
title_full | Answering the Big Clinical Questions in Brain Metastasis Management |
title_fullStr | Answering the Big Clinical Questions in Brain Metastasis Management |
title_full_unstemmed | Answering the Big Clinical Questions in Brain Metastasis Management |
title_short | Answering the Big Clinical Questions in Brain Metastasis Management |
title_sort | answering the big clinical questions in brain metastasis management |
topic | brain metastases stereotactic radiosurgery whole-brain radiotherapy hippocampal avoidance palliative care leptomeningeal disease |
url | https://www.frontiersin.org/articles/10.3389/fonc.2021.834122/full |
work_keys_str_mv | AT johnpkirkpatrick answeringthebigclinicalquestionsinbrainmetastasismanagement AT johnpkirkpatrick answeringthebigclinicalquestionsinbrainmetastasismanagement |